G Acocella

1.4k total citations
46 papers, 1.1k citations indexed

About

G Acocella is a scholar working on Pharmacology, Infectious Diseases and Oncology. According to data from OpenAlex, G Acocella has authored 46 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Pharmacology, 14 papers in Infectious Diseases and 14 papers in Oncology. Recurrent topics in G Acocella's work include Antibiotics Pharmacokinetics and Efficacy (14 papers), Drug Transport and Resistance Mechanisms (11 papers) and Tuberculosis Research and Epidemiology (10 papers). G Acocella is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (14 papers), Drug Transport and Resistance Mechanisms (11 papers) and Tuberculosis Research and Epidemiology (10 papers). G Acocella collaborates with scholars based in Italy and United Kingdom. G Acocella's co-authors include Fabrizio Nicolis, L. T. Tenconi, Barbara H. Billing, Marco Mainardi, C Grassi, M. Marchetti, M Garimoldi, G Gialdroni-Grassi, R Pallanza and Roberto Scotti and has published in prestigious journals such as The Lancet, Gastroenterology and Clinical Infectious Diseases.

In The Last Decade

G Acocella

42 papers receiving 917 citations

Peers

G Acocella

ID

EPIDE

ONCOL

PHARM

E Singlas France

Anne M. Baciewicz United States

Jan Sahai Canada

Klaus‐Dieter Riedel Germany

H. I. Seifart South Africa

D. P. Parkin South Africa

J.Chris Jensen Germany

John H. Wilton United States

Dawna Dressler United States

Kari T Kivist Germany

E Singlas France

G Acocella

355 ×0.9

ID

294 ×1.0

EPIDE

235 ×0.8

ONCOL

310 ×1.0

PHARM

198 ×0.7

PHARM

Citations per year, relative to G Acocella G Acocella (= 1×) peers E Singlas

Countries citing papers authored by G Acocella

Since Specialization

Citations

This map shows the geographic impact of G Acocella's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G Acocella with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G Acocella more than expected).

Fields of papers citing papers by G Acocella

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by G Acocella. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G Acocella. The network helps show where G Acocella may publish in the future.

Co-authorship network of co-authors of G Acocella

This figure shows the co-authorship network connecting the top 25 collaborators of G Acocella. A scholar is included among the top collaborators of G Acocella based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with G Acocella. G Acocella is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

1.

Acocella, G, et al.. (2015). Pharmacokinetic Studies on Antituberculosis Regimens in Humans. American Review of Respiratory Disease.

2.

Acocella, G, et al.. (2002). [Nodular fasciitis in the zygomatic area. Case report and review of the literature].. PubMed. 51(3). 103–6. 3 indexed citations

3.

Acocella, G, et al.. (1996). [ABSORPTION AND BILIARY ELIMINATION OF RIFAMYCIN SV IN HUMANS].. PubMed. 12. 391–400.

4.

Acocella, G. (1989). Human bioavailability studies.. PubMed. 64(1). 38–40; 40. 24 indexed citations

5.

Acocella, G, et al.. (1988). Comparative Bioavailability of Isoniazid, Rifampin, and Pyrazinamide Administered in Free Combination and in a Fixed Triple Formulation Designed for Daily Use in Antituberculosis Chemotherapy: II. Two-Month, Daily Administration Study. American Review of Respiratory Disease. 138(4). 886–890. 32 indexed citations

6.

Acocella, G, et al.. (1988). Comparative Bioavailability of Isoniazid, Rifampin, and Pyrazinamide Administered in Free Combination and in a Fixed Triple Formulation Designed for Daily Use in Antituberculosis Chemotherapy: I. Single-Dose Study. American Review of Respiratory Disease. 138(4). 882–885. 35 indexed citations

7.

Acocella, G, et al.. (1984). Pharmacokinetic study on intravenous rifampicin in man. Pharmacological Research Communications. 16(7). 723–736. 4 indexed citations

8.

Acocella, G, et al.. (1980). Interaction of rifampicin with other drugs. Tubercle. 61(3). 171–177. 31 indexed citations

9.

Acocella, G & Roberto Scotti. (1976). Kinetic studies on the combination rifampicin-trimethoprim in man. Journal of Antimicrobial Chemotherapy. 2(3). 271–277. 15 indexed citations

10.

Acocella, G, et al.. (1974). Kinetic studies on rifampicin. III. Effect of phenobarbital on the half-life of the antibiotic.. PubMed. 17(3). 151–8. 7 indexed citations

11.

Acocella, G, et al.. (1973). Serum concentrations and biliary excretion of bilirubin during short-term treatment with rifampicin.. PubMed. 16(3). 186–90. 6 indexed citations

12.

Acocella, G, et al.. (1972). Kinetic studies on rifampicin. European Journal of Clinical Pharmacology. 5(2). 111–115. 14 indexed citations

13.

Acocella, G, et al.. (1972). Kinetics of rifampicin and isoniazid administered alone and in combination to normal subjects and patients with liver disease. Gut. 13(1). 47–53. 88 indexed citations

14.

Acocella, G, et al.. (1971). Kinetic Studies on Rifampicin. Chemotherapy. 16(6). 356–370. 81 indexed citations

15.

Acocella, G, et al.. (1971). Recurrent intrahepatic jaundice. Clinical and laboratory findings in three siblings.. PubMed. 14(1). 46–58. 1 indexed citations

16.

Acocella, G, et al.. (1967). [Study on the chemotherapy of experimental lead poisoning. 1. Effects of lead poisoning on the tryptophan to nicotinic acid metabolism in the rat].. PubMed. 20(5). 189–94. 3 indexed citations

17.

Acocella, G, et al.. (1966). Study of the excretion in bile and concentration in the gall bladder wall of rifamide.. Gut. 7(4). 380–386. 6 indexed citations

18.

Acocella, G, et al.. (1963). Assorbimento ed eliminazione biliare della rifamicina SV nell’uomo. Chemotherapy. 7(5). 391–400. 3 indexed citations

19.

Acocella, G, et al.. (1962). [Comparative study, in normal subjects and liver disease patients, of the absorption and elimination of rifomycin SV administered in a single oral or intramuscular dose].. PubMed. 14. 548–51. 1 indexed citations

20.

Acocella, G, et al.. (1961). [Demonstration of the existence, in man, of an entero-hepatic circulation of rifomycin SV].. PubMed. 75. 1490–3. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact